United States · FDA National Drug Code directory
Betamethasone Sodium Phosphate and Betamethasone Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0517-0720_873bd493-ff1c-4cbb-960a-b1e8d73ab366
- Product NDC
- 0517-0720
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Betamethasone Sodium Phosphate and Betamethasone Acetate
- Labeler
- American Regent, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100428
- Source listing expiry
- 20261231
Source-listed ingredients
- BETAMETHASONE ACETATE — 3 mg/mL
- BETAMETHASONE SODIUM PHOSPHATE — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0720-01) / 5 mL in 1 VIAL, MULTI-DOSE · 0517-0720-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →